{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:51:19Z","timestamp":1791669079336,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05950-1","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:30:22Z","timestamp":1791667822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tirofiban after intravenous thrombolysis in acute ischemic stroke patients: An updated systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","author":[{"given":"Omar Fayez","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Almarfadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour Aldin Tarek","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Magdy","family":"Siam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roaa","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Aljalawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman M.","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherief","family":"Ghozy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam A.","family":"Dmytriw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"issue":"9","key":"5950_CR1","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2314779","volume":"391","author":"O Adeoye","year":"2024","unstructured":"Adeoye O, Broderick J, Derdeyn CP, Grotta JC, Barsan W, Bentho O et al (2024) Adjunctive intravenous argatroban or eptifibatide for ischemic stroke. N Engl J Med 391(9):810\u2013820","journal-title":"N Engl J Med"},{"issue":"4","key":"5950_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153\u2013160","journal-title":"Evid Based Ment Health"},{"key":"5950_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-026-04892-8","author":"S Bano","year":"2026","unstructured":"Bano S, Ahmed FW, Saeed A, Nawazish A, Haris M, Mansoor A et al (2026) Efficacy and safety of tirofiban following intravenous thrombolysis: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol. https:\/\/doi.org\/10.1186\/s12883-026-04892-8","journal-title":"BMC Neurol"},{"issue":"8","key":"5950_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jama.2023.0550","volume":"329","author":"H-S Chen","year":"2023","unstructured":"Chen H-S, Cui Y, Zhou Z-H, Dai Y-J, Li G-H, Peng Z-L et al (2023) Effect of argatroban plus intravenous alteplase vs intravenous alteplase alone on neurologic function in patients with acute ischemic stroke: the ARAIS randomized clinical trial. JAMA 329(8):640\u2013650","journal-title":"JAMA"},{"issue":"7650","key":"5950_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926","journal-title":"BMJ"},{"issue":"22","key":"5950_CR6","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1001\/jama.2026.5245","volume":"335","author":"X Liu","year":"2026","unstructured":"INSTANT Trial Authors for the INSTANT Investigators, Liu X, Zhang F, Zhang C, Li Z, Yuan G et al (2026) Intravenous tirofiban after tenecteplase in acute ischemic stroke: the INSTANT randomized clinical trial. JAMA 335(22):1949\u20131958","journal-title":"JAMA"},{"issue":"1","key":"5950_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12883-022-02808-w","volume":"22","author":"Z Liang","year":"2022","unstructured":"Liang Z, Zhang J, Huang S, Yang S, Xu L, Xiang W et al (2022) Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study. BMC Neurol 22(1):280","journal-title":"BMC Neurol"},{"issue":"4","key":"5950_CR8","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.044","volume":"28","author":"J Liu","year":"2019","unstructured":"Liu J, Shi Q, Sun Y, He J, Yang B, Zhang C et al (2019) Efficacy of tirofiban administered at different time points after intravenous thrombolytic therapy with alteplase in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 28(4):1126\u20131132","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"5950_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5853\/jos.2023.02250","volume":"26","author":"R Liu","year":"2024","unstructured":"Liu R, Liang Z, Li W, Zhan Y, Xu L, Yang S et al (2024) Adding tirofiban on top of recombinant tissue plasminogen activator may improve clinical outcome in acute stroke patients. J Stroke 26(1):121\u2013124","journal-title":"J Stroke"},{"key":"5950_CR10","unstructured":"Omarfayezabbas\/Meta4Every-1 (2026) V1. Zenodo"},{"issue":"1","key":"5950_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):89","journal-title":"Syst Rev"},{"key":"5950_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"issue":"12","key":"5950_CR13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2503678","volume":"393","author":"C Tao","year":"2025","unstructured":"Tao C, Liu T, Cui T, Liu J, Li Z, Ren Y et al (2025) Early Tirofiban infusion after intravenous thrombolysis for stroke. N Engl J Med 393(12):1191\u20131201","journal-title":"N Engl J Med"},{"key":"5950_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.982684","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang J, Ma Z, Mu G, Liang D, Li Y et al (2022) Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis. Front Neurol 13:982684","journal-title":"Front Neurol"},{"issue":"9843","key":"5950_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","volume":"380","author":"SM Zinkstok","year":"2012","unstructured":"Zinkstok SM, Roos YB (2012) ARTIS investigators. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet 380(9843):731\u2013737","journal-title":"Lancet"},{"issue":"10","key":"5950_CR16","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1161\/STROKEAHA.114.006268","volume":"45","author":"SM Zinkstok","year":"2014","unstructured":"Zinkstok SM, Beenen LF, Majoie CB, Marquering HA, de Haan RJ, Roos YB (2014) Early deterioration after thrombolysis plus aspirin in acute stroke: a post hoc analysis of the antiplatelet therapy in combination with recombinant t-PA thrombolysis in ischemic stroke trial. Stroke 45(10):3080\u20133082","journal-title":"Stroke"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05950-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05950-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05950-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:30:23Z","timestamp":1791667823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05950-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":16,"alternative-id":["5950"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05950-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"1 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}